SCHEMBL14699541

SCHEMBL14699541

NCCCN1C=CC2=C(CCC=C2)c2ccc(Cl)cc21

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL15900287 0.99 ALDH1A1 (0.32) ALDH1A1
SCHEMBL14721914 0.89 NUDT1 (0.31) —
SCHEMBL7168223 0.82 HTR2A (0.30) —
SCHEMBL15559609 0.77 CDK1 (0.37) ALDH1A1
SCHEMBL4913656 0.71 HRH1 (0.44) ALDH1A1
SCHEMBL5495047 0.70 SLC6A9 (0.34) —
SCHEMBL14722203 0.69 — —
Hydrochloric Acid SCHEMBL14697569 0.67 — —
SCHEMBL14706998 0.60 HTR2A (0.60) —
Hydrochloric Acid SCHEMBL7845930 0.60 HTR2A (0.57) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2744808-A2 TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS Mount Sinai School of Medicine (US) 2014-06-25 — — EP disclosed
WO-2013025882-A2 TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS MT. SINAI SCHOOL OF MEDICINE (US) 2013-02-21 — — WO disclosed
Send feedback